JB Hunt Gains, GH Research Rises, Abbott Laboratories Surges on 2026 Profit Guidance Raise

On this episode of Stock Movers:
- JB Hunt (JBHT) shares gain after the trucking company reported adjusted earnings per share for the second quarter that beat the average analyst estimate. Analysts highlight progress in the firm’s intermodal business, where the company uses two or more modes of transportation.
- GH Research (GHRS) rises as analysts call it a beneficiary of interest in psychedelics after the Lilly-AtaiBeckley deal. Eli Lilly & Co. agreed to buy AtaiBeckley Inc. for as much as $3.8 billion, underscoring growing interest from large drugmakers in psychedelic medicine.
- Abbott Laboratories (ABT) shares surge. Abbott raised its 2026 profit guidance after a stronger-than-expected second quarter driven by improved performance across most of its business lines. The company now expects adjusted earnings to fall between $5.45 to $5.60 a share this year, and shares rose 14% after the announcement.

See omnystudio.com/listener for privacy information.